Increasing Aging Population to Boost Heparin Market Growth
                     Increasing Aging Population to Boost 
Heparin Market Growth
As per Inkwood Research, the Global Heparin Market is set to progress with a CAGR of 4.01% in 
terms of revenue during the forecasting years 2024-2032.
Heparin, an organic compound composed of a diverse array of molecules associated with 
carbohydrates, is primarily employed in laboratories to prevent blood coagulation in collected blood 
samples. Naturally occurring in the lungs and liver, heparin exists in two main forms: unfractionated 
and low molecular weight heparin. 
REQUEST FREE SAMPLE LINK – https://www.inkwoodresearch.com/reports/heparin-
market/#request-free-sample 
Surging Geriatric Populace to Boost Global Heparin Market Growth
With the global population aging, there’s an increasing demand for healthcare solutions tailored to 
older individuals’ specific needs. According to the World Health Organization, the proportion of older
adults is projected to nearly double from 12% to 22% between 2015 and 2050, with 1 in 6 people 
worldwide aged 60 or older by 2030.
Common age-related conditions like chronic obstructive pulmonary disease (COPD), atrial fibrillation,
and coronary artery disease necessitate anticoagulant therapy, making heparin a crucial medication 
and contributing to market expansion.
Low Molecular Weight Heparin: Key Heparin Type by 2032
Light-molecular weight heparin (LMWH) is an anticoagulant medication designed to minimize the 
risk of blood clots, including conditions like pulmonary embolism and deep vein thrombosis (DVT). 
Derived from unfractionated heparin (UFH), LMWH has smaller molecules, enhancing ease of use 
and reducing the likelihood of certain adverse effects compared to regular heparin.
North America: Significant Region During the Forecast Period 
The incidence of thromboembolic and cardiovascular conditions is increasing in North America, with 
CVD alone claiming one life every 33 seconds in the US, according to the Centers for Disease Control 
and Prevention (CDC). The market in North America benefits from the prominent positions of key 
pharmaceutical companies like Pfizer and Baxter, driving the growth of the heparin market in the 
region.
Some of the leading companies operating in the market include Dr. Reddy’s Laboratories Ltd, Aspen 
Pharmacare Holdings Limited, Opocrin SpA, etc.
Request for Customization: https://inkwoodresearch.com/request-for-custom-report/
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. 
Market intelligence studies with relevant fact-based research are customized across industry 
verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an 
objective comprehension that acknowledges the business environments. Our geographical analysis 
comprises North & South America, CEE, CIS, the Middle East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
[email protected]
1-(857)293-0150
Related Reports:
GLOBAL ANTICOAGULANTS MARKET